KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Short-term Investments (2016 - 2025)

Globus Medical (GMED) has disclosed Short-term Investments for 13 consecutive years, with $31.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments fell 70.57% year-over-year to $31.1 million, compared with a TTM value of $31.1 million through Dec 2025, down 70.57%, and an annual FY2025 reading of $31.1 million, down 70.57% over the prior year.
  • Short-term Investments was $31.1 million for Q4 2025 at Globus Medical, up from $18.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $306.4 million in Q2 2023 and bottomed at $18.8 million in Q3 2025.
  • Average Short-term Investments over 5 years is $174.6 million, with a median of $191.5 million recorded in 2021.
  • The sharpest move saw Short-term Investments plummeted 82.92% in 2023, then surged 109.16% in 2024.
  • Year by year, Short-term Investments stood at $250.4 million in 2021, then rose by 18.06% to $295.6 million in 2022, then tumbled by 82.92% to $50.5 million in 2023, then soared by 109.16% to $105.6 million in 2024, then crashed by 70.57% to $31.1 million in 2025.
  • Business Quant data shows Short-term Investments for GMED at $31.1 million in Q4 2025, $18.8 million in Q3 2025, and $105.6 million in Q4 2024.